Concepedia

Adina Hughes

AH

8

Publications

497

Citations

8

H-Index

2018

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (Singapore)

AstraZeneca (United States)

AstraZeneca (Japan)

AstraZeneca (Brazil)

Adina Hughes is an author at AstraZeneca (United Kingdom) specializing in cancer research, cell biology, and t cell immunity.

ORCID

Top concepts

Publications per year

2018–2024

8

Publications

8

Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically

Lucy C. Riches, Antonio G. Trinidad, Gareth Hughes et al. · Molecular Cancer Therapeutics · 2019 · 155 citations · Full text

Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance

Violeta Serra, Anderson T. Wang, Marta Castroviejo‐Bermejo et al. · Clinical Cancer Research · 2022 · 80 citations · Full text

Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer

Alexey S. Revenko, Larissa S. Carnevalli, Charles Sinclair et al. · Journal for ImmunoTherapy of Cancer · 2022 · 77 citations · Full text

Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity

Sophie Langdon, Adina Hughes, Molly A. Taylor et al. · OncoImmunology · 2018 · 51 citations · Full text

, , +25

<i>STAT3</i> Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1

Theresa A. Proia, Maneesh Singh, Richard Woessner et al. · Clinical Cancer Research · 2020 · 50 citations · Full text

Rows per page

1–5 of 8